• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 10, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

LIM domain only 1: One gene, many roles in cancer

Bioengineer by Bioengineer
September 6, 2025
in Biology
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers detail another gene target that could be the crucial link to curing different cancers

Credit: Chinese Medical Journal

LMO1 codes for a protein ‘connector’ that helps in the assembly of biomolecules involved in the production of RNA molecules, which in turn, leads to the synthesis of proteins implicated in cancer formation. This generates hope for devising ways to manipulate LMO1, which could take modern medicine one step closer to curing cancer. As such, a group of medical researchers from Affiliated Hospital of Hebei University in China, and Texas State University in USA, took it upon themselves to answer this question better, through a review published in Chinese Medical Journal.

The researchers scanned several studies on LMO1 to determine its key molecular features. On the question of why they narrowed their focus on LMO1, Professor You-Chao Jia of Affiliated Hospital of Hebei University, who led the study, explains, “Unique biological features of LMO1 distinct from other LMO members, such as its tissue-specific expression patterns, interacting proteins, and transcriptional targets, have been increasingly recognized. Studies indicated that LMO1 plays a critical oncogenic role in various types of cancers, including T-cell acute lymphoblastic leukemia, neuroblastoma, gastric cancer, lung cancer, and prostate cancer.”

The protein ‘connectors’ that LMO1 codes for are called as transcription cofactors (COF). Much like a puppeteer who manipulates strings to move the puppets in different ways, the LMO1 COF acts through its protein products to effect various cancer-causing changes in the cell. Here, it is important to note that these protein products regulate expression by binding to the DNA. So, through their DNA-binding protein counterparts, LMO1 COF extensively interacts with other important components of the cell and facilitates production of other proteins, essentially functioning as a carcinogenic ‘power-broker’ of sorts. Accordingly, the researchers stress the importance of better studying the LMO1 interactome and transcriptome in the review.

Moving to a higher level of organization, the researchers also looked into the tissue-specific expression of LMO1 in cancer. Here again, they identified the mediation of LMO1 activities through its DNA-binding ‘partners’. So, they propose that the analysis of cancer condition should incorporate not only LMO1 expression, but also nuances in their partners’ expression. They observed similar correlations at the epigenetic level too.

Further, the researchers highlight the role of random unique genetic changes called single nucleotide polymorphisms (SNPs) in the LMO1 as possible contributors to carcinogenesis. They specifically identified LMO1 SNP contributions to T-cell acute lymphoblastic leukemia and neuroblastoma.

Needless to say, the researchers highlight the diagnostic value of LMO1 expression levels. They observed from several studies that the overexpression of LMO1 is implicated in poor patient clinical outcomes in different cancers. Therefore, they believe that with a little more analysis, LMO1 expression levels could well become the clinical determiner of cancer progression in affected patients. Also, they implied that further research into the gene could lead to targeted therapy for these cancers.

Overall, the researchers have made a convincing argument to take a better look at LMO1 for devising more effective cures for different cancers. In this regard, Professor Jia hopes, “LMO1 is an oncogene or a key factor in carcinogenesis in many kinds of cancers. We hope that more studies will be carried out to explore its application value in clinical treatment of tumors.” The world can indeed be optimistic about a possible breakthrough in cancer cure, through this review.

###

Reference

Title of original paper: LIM domain only 1: an oncogenic transcription cofactor contributing to the tumorigenesis of multiple cancer types.

Journal: Chinese Medical Journal

DOI: http://doi.org/10.1097/CM9.0000000000001487

Media Contact
Peifang Wei
[email protected]

Related Journal Article

http://dx.doi.org/10.1097/CM9.0000000000001487

Tags: BiochemistryBiologycancerCell BiologyClinical TrialsGene TherapyGenesGeneticsMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Critically Endangered Shark Meat Frequently Sold Under False Labels in US, Study Finds

September 10, 2025
blank

Fermented Poncirus Extract Inhibits Fat Cell Formation

September 10, 2025

Life at the Edge: Exploring Survival Within Arctic Ice

September 10, 2025

Decoding Animal Decision-Making: NIH Funds Groundbreaking Research on Exploration vs. Exploitation

September 9, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    52 shares
    Share 21 Tweet 13
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Critically Endangered Shark Meat Frequently Sold Under False Labels in US, Study Finds

Misconceptions Prevent Certain Cancer Patients from Accessing Hormone Therapy Benefits

New ECU Study Reveals Muscle Loss in Children During Early Cancer Treatment: A Hidden Threat to Recovery

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.